Apr 1, 2025 7:30 am EDT Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 20, 2025 7:30 am EDT Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
Mar 4, 2025 9:00 am EST Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference
Mar 3, 2025 7:30 am EST Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 3, 2025 7:30 am EST Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 31, 2024 7:30 am EST Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 2, 2024 7:30 am EST Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 14, 2024 7:30 am EST Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
Nov 12, 2024 7:30 am EST Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
Nov 4, 2024 7:30 am EST Abeona Therapeutics® Announces Participation in November Investor Conferences
